Trial Profile
A Pilot, Prospective, Post-Marketing Study Assessing the On-Treatment Dabigatran Levels in Dabigatran-Treated Patients with Non-Valvular Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Pharmacokinetics
- 15 May 2018 New trial record
- 08 May 2018 Results published in the Drugs and Aging Journal.